The Trump administration is escalating U.S. drug wars in Latin America as a cover for imperialism.
While the administration directs a military buildup in the Caribbean, killing people who it claims are drug smugglers, it is preparing to intervene in Latin American countries for the purpose of opening their markets to U.S. businesses. The administration’s priority is gaining access to Latin American resources, a main focus of its foreign policy, just as the highest-level officials have indicated.
“Increasingly, on geopolitical issue after geopolitical issue, it is access to raw material and industrial capacity that is at the core both of the decisions that we’re making and the areas that we’re prioritizing,” Secretary of State Marco Rubio said in June.
Drug War Imperialism
One of the major contributions of the United States to imperial history is drug war imperialism. Developed as part of the so-called “war on drugs,” which the Nixon administration began in the 1970s and the Reagan administration expanded in the 1980s, drug war imperialism has been one of the primary means by which the United States has intervened in Latin America.
During the late 1980s, the United States set the standard for drug war imperialism in Panama. After discrediting Manuel Noriega with drug charges, officials in Washington organized a military intervention to remove the Panamanian ruler from power.
Under the direction of the George H. W. Bush administration, the U.S. military invaded Panama, captured Noriega, and brought him to the United States, where he was tried, convicted, and imprisoned on drug charges. U.S. officials framed the operation as part of the war on drugs, but their primary concern was bringing to power a friendly government that acted on behalf of U.S. interests. U.S. officials valued Panama for its location and for the Panama Canal, a critical node for U.S. trade.
In the following decades, the United States exercised other forms of drug war imperialism in Latin America. In 2000, the administration of Bill Clinton implemented Plan Colombia, a program of U.S. military support for the Colombian government. U.S. officials framed Plan Colombia as a counter-narcotics program, but their objective was to empower the Colombian military in its war against leftist revolutionaries, especially the Revolutionary Armed Forces of Colombia (FARC).
In 2007, the administration of George W. Bush pushed forward a similar program in Mexico. With the Mérida Initiative, the Bush administration empowered the Mexican government to intensify its war against drug cartels. U.S. officials saw the program as way to forge closer relations with the Mexican military and confront the country’s drug traffickers, who were making it difficult for U.S. businesses to operate in the country.
Multiple administrations faced strong criticisms over the programs, especially as drug-related violence increased in Colombia and Mexico. A Colombian truth commission estimated that 450,000 people were killed in Colombia from 1985 to 2018, with 80 percent of the deaths being civilians. There have been hundreds of thousands of drug-related deaths in Mexico, with the numbers still increasing by tens of thousands every year.
Although most U.S. officials insisted that criminal organizations in Latin America bore primary responsibility for drug-related violence, some began to question the U.S. approach. They wondered whether U.S.-backed drug wars were ignoring root causes of the drug problem, such as the U.S. demand for drugs.
“As Americans we should be ashamed of ourselves that we have done almost nothing to get our arms around drug demand,” Secretary of Homeland Security John Kelly said in 2017. “And we point fingers at people to the south and tell them they need to do more about drug production and drug trafficking.”
In recent years, some critics have even cast the drug wars as a failure. Decades of U.S.-backed military operations, they have noted, have brought terrible violence to Latin America while failing to stop the flow of drugs to the United States.
“Drugs have kept flowing, and Americans and Latin Americans have kept dying,” Shannon O’Neil, who chaired a congressionally-mandated drug policy commission, told Congress in 2020. “Something is not working.”
Keep reading
You must be logged in to post a comment.